Legislation and Legislative Advocacy
The American Hospital Association (AHA) shares resources on health care legislation being considered by the U.S. House and Senate and legislative advocacy opportunities for hospitals and health systems.
The American Hospital Association and others support Senators Grassley and Feinstein of the Senate Judiciary Committee for their leadership and commitment to reducing out-of-control prescription drug prices and stopping anti-competitive abuses that keep drug prices high.
Read the full letter below…
The House Energy and Commerce Health Subcommittee today held a hearing on draft legislation that would reauthorize the Pandemic and All-Hazards Preparedness Act through 2023.
President Trump today signed into law AHA-supported bipartisan legislation (S. 2372) to streamline and consolidate the Department of Veterans Affairs' community care programs into a permanent Veterans Community Care Program.
AHA letter to Energy and Commerce Committee Subcommittee on Health’s discussion draft, titled the “Pandemic and All-Hazards Preparedness Reauthorization Act of 2018.”
AHA Statement to the Committee on Ways and Means for “Hearing on Lowering Costs and Expanding Access to Health Care through Consumer-Directed Health Plans.”
Virginia legislators yesterday voted to approve a budget bill that would expand access to Medicaid coverage to as many as 400,000 low-income residents.
Sen. Bill Cassidy (R-LA) yesterday released a white paper with ideas on increasing affordability in health care.
The Centers for Medicare & Medicaid Services yesterday issued a notice detailing proposed changes to a claim-review demonstration project for Medicare fee-for-service home health services.
The Senate Finance Committee today held a hearing on “Rural Health Care in America: Challenges and Opportunities.”
The Senate Judiciary Committee today approved five bills to address the opioid crisis, which include provisions aimed at increasing participation in drug take-back programs, strengthening Drug Enforcement Administration discretion in setting opioid quotas, and reducing demand for illicit narcotics.